Effects of interferon-α2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis

Annals of Hematology

Volumn 79, Issue 12, 2000, Pages 660-666

  Schernthaner, G H ^a   Spanblochl E ^a   Sperr, W R ^a   Sillaber, C ^a   Semper, H ^a   Jurecka, W ^b   Hagen, W ^a   Wolff, K ^b   Chott, A ^b   Lechner, K ^a   Valent, P ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Histamine; Interferon ; Mastocytosis; Progenitor cells; Tryptase

Indexed keywords

ALPHA2B INTERFERON; HISTAMINE; METHOXSALEN; TRYPTASE; ALPHA INTERFERON; ALPHA2 INTERFERON; INTERFERON-ALPHA 2;

ADULT; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; HISTAMINE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MALE; MAST CELL; MYELOPOIESIS; PRIORITY JOURNAL; STEM CELL; SYSTEMIC MASTOCYTOSIS; BLOOD; CYTOLOGY; DRUG EFFECT; MASTOCYTOSIS;

ADULT; CELL DIFFERENTIATION; HUMANS; INTERFERON-ALPHA; MALE; MAST CELLS; MASTOCYTOSIS; STEM CELLS;

EID: 0034353292     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000206     Document Type: Article

References (47)

1. -, colony forming cell
2. A case of malignant mastocytosis with circulating mast cell precursors: Biologic and phenotypic characterization of the malignant clone
3. Sytemic mastocytosis and other mast cells neoplasms
4. Interferons
5. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells
6. Response of severe systemic mastocytosis to interferon alpha
7. The natural course of urticaria pigmentosa
8. Evaluation of human peripheral blood leukocytes for mast cell tryptase
9. Interferon treatment of patients with chronic urticaria and mastocytosis
10. Interferon-alpha in combination with corticosteroids improves systemic mast cell disease
11. Regulation of mRNA levels of TNF-alpha and the alpha chain of the high-affinity receptor for IgE in mast cells by IFN-gamma and alpha/beta
12. Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia
13. Treatment of systemic mastocytosis with interferongamma: Failure after appearance of anti-IFN-gamma antibodies
14. Origin of human mast cells: Development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation
15. Interferon alpha and systemic mastocytosis. Analysis of therapeutic efficacy in 6 cases
16. Systemic mastocytosis - A case treated with interferon alpha and radiotherapy
17. Systemic mastocytosis: Retrospective review of a decade's clinical experience at the Brigham and Women's Hospital
18. Bone marrow findings in systemic mastocytosis
19. Diagnostic value of staining for tryptase in patients with mastocytosis
20. Recombinant human stem cell factor stimulates differentiation of human mast cells from dispersed fetal liver cells
21. Pediatric mastocytosis
22. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells
23. Inhibition of human mast cell growth and differentiation by interferon gamma-1b
24. Response to interferon alfa-2b in a patient with systemic mastocytosis
25. Treatment of urticaria pigmentosa using interferon alpha
26. Severe osteoporosis due to systemic mast cell disease: Successful treatment with interferon alpha-2B
27. Mast cells and mast cell neoplasia: A review
28. Long-term effect of interferon alpha treatment in mastocytosis
29. Classification and diagnosis of mastocytosis: Current status
30. The treatment of mastocytosis: An overview
31. Specificity high-affinity receptors for interferon-gamma on mousse bone marrow-derived mast cells: Inhibitory effect of interferon-gamma on mast cell precursors
32. Anaphylactic-like syndrome in systemic mastocytosis treated with alpha-2-interferon
33. Tissue mast cells in health and disease
34. Systemic mastocytosis associated with chronic myelomonocytic leukemia: Clinical features and response to interferon alpha therapy
35. - cell population
36. Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis
37. Tryptase levels as an indicator of mast cell activation in systemic anaphylaxis and mastocytosis
38. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis
39. Type beta transforming growth factors promote interleukin-3 (IL-3)-dependent differentiation of human basophils but inhibit IL.·3-dependent differentiation of human eosinophils
40. Interferon alpha/beta inhibits IgE dependent histamine release from rat mast cells
41. Antiproliferative effect of IFN-gamma on proliferation of mouse connective tissue type mast cells
42. Systemic mastocytosis with extensive polypoid lesions in the intestines; successful treatment with interferon-alpha
43. Biology, classification and treatment of human mastocytosis
44. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor (SCF)/kit ligand (KL) in long term culture
45. Recent advances in mastocytosis research. Summary of the vienna mastocytosis meeting in 1998
46. Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b
47. Treatment of three patients with systemic mastocytosis with interferon alpha-2b